Clinical Trial Update: Abuse Liability of Pregabalin and Its Effects on Benzodiazepine Withdrawal Symptoms [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the abuse liability of pregabalin and its effects on benzodiazepine withdrawal symptoms; the study was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benzodiazepine Dependence
• Substance Use Disorder

Drugs mentioned

• Pregabalin (Pregabalin)

Snippet

Sponsor: Centre for Addiction and Mental Health | Conditions: Substance-Related Disorders | Phase 4 | Status: TERMINATED